Recent Update to Russia’s Essential Drugs List and Seven Nosologies: Clinical Differentiation and Local Manufacturing Implications for New Drug Inclusion

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.09.1874
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Inclusion of Ipragliflozin Into the Vital and Essential Drugs List: Budget Impact Analysis

Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор)
2019English

Php236 - Quality of Evidence on the Cost-Effectiveness of Drugs Proposed for the Inclusion in the Russian Vital and Essential Drugs List in 2014-2017

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Inclusion of TB Diagnostics on the WHO Essential Diagnostics List

International Journal of Tuberculosis and Lung Disease
MedicinePulmonaryInfectious DiseasesRespiratory Medicine
2018English

Local Anesthetics and Steroids: Contraindications and Complications - Clinical Update

Acta Clinica Croatica
Medicine
2019English

Myeloid Cell Origins, Differentiation, and Clinical Implications

2017English

New Drugs Prompt Myeloma Guidelines Update

Cancer Discovery
Oncology
2016English

Role of Essential Drug List in Effective Management of Essential Anti- Malarial Drugs in Healthcare System of Pakistan Challenges in Policy Development to Practice

Pharmaceutical Regulatory Affairs: Open Access
2014English

Anti-Hypertensive Drugs and Left Ventricular Hypertrophy: A Clinical Update

Internal and Emergency Medicine
Internal MedicineEmergency Medicine
2011English

Drug Permeation and Metabolism in Mycobacterium Tuberculosis : Prioritising Local Exposure as Essential Criterion in New TB Drug Development

IUBMB Life
BiochemistryGeneticsClinical BiochemistryCell BiologyMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy